Sihuan Pharmaceutical Holdings Group Stock Value
Sihuan Pharmaceutical Holdings Group Company Info
EPS Growth 5Y
-42,57%
Market Cap
HK$12,93 B
Long-Term Debt
HK$0,77 B
Quarterly earnings
08/29/2026 (E)
Dividend
HK$0,02
Dividend Yield
1,53%
Founded
2001
Industry
Country
ISIN Number
Website
Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.
HK$2,00
39.86%
Last Update: 04/11/2026
Analysts: 1
Highest Price Target HK$2,00
Average Price Target HK$2,00
Lowest Price Target HK$2,00
In the last five quarters, Sihuan Pharmaceutical Holdings Group’s Price Target has risen from HK$2,67 to HK$2,67 - a 0,00% increase. One analysts predict that Sihuan Pharmaceutical Holdings Group’s share price will increase in the coming year, reaching HK$2,00. This would represent an increase of 39,86%.
Top growth stocks in the health care sector (5Y.)
What does Sihuan Pharmaceutical Holdings Group do?
Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China. The company primarily operates in medical aesthetic products, innovative medicines, and generic medicines.
Business Segments
The company operates through three primary reportable operating segments: Medical Aesthetic Products, Innovative Medicine and Other Medicines...
Sihuan Pharmaceutical Holdings Group Questions and Answers
Which sectors generate sales and which are the top 3 markets?
**Pharmaceutical Products:** 60%
**Medical Devices:** 25%
**Biotechnology:** 15%
**TOP 3 Markets:**
**China:** 70%
**Southeast Asia:** 15%
**Latin America:** 10%
Sihuan Pharmaceutical Holdings Group Ltd. generates the majority of its revenue from the sale of pharmaceutical products,...
At which locations are the company’s products manufactured?
**Production Sites:** China
Sihuan Pharmaceutical Holdings Group Ltd. mainly produces its products in China. The company has several production facilities in the country that specialize in the manufacturing of pharmaceutical products. These sites are strategically chosen to optimize logistics and e...
What strategy does Sihuan Pharmaceutical Holdings Group pursue for future growth?
**Focus on Research and Development:** 15% of revenue (estimated for 2026)
**Expansion of Product Portfolio:** Introduction of 5 new medications (planned by 2026)
**International Expansion:** Market entry into 3 new countries (planned by 2026)
Sihuan Pharmaceutical Holdings Group Ltd. pursues a s...
Which raw materials are imported and from which countries?
**Imported Raw Materials:** Current data not available
**Main Supplier Countries:** China, India, USA (estimated, based on industry trends)
Sihuan Pharmaceutical Holdings Group Ltd. is a significant pharmaceutical company specializing in the development and production of drugs. Like many pharmaceu...
How strong is the company’s competitive advantage?
**Market share in China:** 5% (estimated, 2026)
**R&D expenses:** 12% of revenue (2025)
**Patent portfolio:** Over 200 active patents (2025)
Sihuan Pharmaceutical Holdings Group Ltd. has a significant competitive advantage due to its strong presence in the Chinese market, where it holds an...
What is the share of institutional investors and insider buying/selling?
**Institutional Investor Share:** Estimated 45% (2026)
**Insider Buys/Sells:** No significant transactions in the last year (2026)
The institutional investor share in Sihuan Pharmaceutical Holdings Group Ltd. is estimated to be around 45%. This indicates a strong interest from institutional inves...
What percentage market share does Sihuan Pharmaceutical Holdings Group have?
**Market share of Sihuan Pharmaceutical:** Estimated at 4% (2026)
**Top competitors and their market shares:**
1. **Sinopharm Group Co. Ltd.:** 15%
2. **Shanghai Pharmaceuticals Holding Co. Ltd.:** 12%
3. **China Resources Pharmaceutical Group Ltd.:** 10%
4. **Hengrui Medicine:** 8%
5. **CSPC Pharm...
Is Sihuan Pharmaceutical Holdings Group stock currently a good investment?
**Revenue Growth:** 10% (2025)
**Research and Development Ratio:** 15% of revenue (2025)
**Market Share in China:** 5% in the pharmaceutical products sector (2025)
Sihuan Pharmaceutical Holdings Group Ltd. recorded a revenue growth of 10% in 2025, attributed to successful expansion of their product...
Does Sihuan Pharmaceutical Holdings Group pay a dividend – and how reliable is the payout?
**Dividend payment:** No dividend (2026)
Sihuan Pharmaceutical Holdings Group Ltd. has not paid any dividends in recent years. The company is focusing more on reinvesting in research and development and expanding into new markets to ensure long-term growth.
The reliability of dividend payments is...
